09 May 2018 Research
Sharing this exciting news: a treatment advance for childhood leukaemia
A deal has been struck to let the NHS offer children an expensive new cancer therapy that has been called the most exciting treatment advance for decades.
“We are excited at this breakthrough in the treatment for childhood leukaemia. CAR-T cell therapy gives those children who do not respond to chemotherapy treatment a real chance of a long-term cure. We welcome this significant step forward which will give hope to families whose children are affected by leukaemia.”
Dr Maria Gilleece, Director, Yorkshire Blood and Marrow Transplant Programme and a member of the Leukaemia UK Medical Panel.
Related posts
16 November 2022
Cost of Living with Leukaemia Fund launches
Leukaemia Care and Leukaemia UK have launched a new financial support service, the Cost of Living with Leukaemia Fund, in response to the cost of living crisis in the UK….
11 February 2021
Why I became a Leukaemia UK Trustee
Caroline Evans – Leukaemia UK Trustee and Projects Consultant – reflects on why she became a Trustee and what drives her in the role.
31 October 2022
Leukaemia UK appoints new Director of Communications job share from Shelter to lead their ambitious strategy
Blood cancer research charity, Leukaemia UK, has hired Anna Wilson and Lizzie Afonso from housing and homelessness charity, Shelter, to job-share its new Communications Director role. This is the first…
4 August 2020
Our life-saving work must continue
Leukaemia and other blood cancers don’t stop for coronavirus (COVID-19) and our vital research and care must continue